Freestone Grove Partners LP Adma Biologics, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 44,816 shares of ADMA stock, worth $720,193. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,816Holding current value
$720,193% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$300 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$292 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$239 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$182 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$88.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.16B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...